AliveCor enters India with personal ECG device


California-based AliveCor has announced its entry in the Indian market with the launch of the personal ECG device, KardiaMobile 6L. Owing to the accessibility challenges to quality healthcare in the country and COVID related infection fears, the portable and technology-enabled ECG device is expected to help deliver affordable and convenient heart care to over 260 million heart patients and those at risk, without visiting a hospital.

KardiaMobile 6L is a personal ECG device that can detect the three most common arrhythmias or irregular heartbeat—atrial fibrillation (AFib), bradycardia, and tachycardia, which require regular monitoring and a healthy lifestyle. AliveCor’s technology gives patients the ability to record a medical-grade ECG in just 30 seconds, with no hospital visits and complete peace of mind. The device is small enough to fit in a pocket, allowing users to check in on their heart anytime, anywhere right from their smartphone.

Talking about the relevance of the device for the Indian market AliveCor founder and Chief Medical Officer, Dr David Albert said in a statement, “In India alone, there are more than 250 million people at risk of heart disease. That’s a substantial portion of the population. And with the ongoing pandemic and stay-at-home orders in place, many people find it hard to get even the routine healthcare they need for fear of increasing their risk of exposure to COVID-19. KardiaMobile’s launch in India not only makes it easier for people to stay on top of their heart health from home, but it also saves time, money, and resources for India’s healthcare system as they continue to fight coronavirus and care for those in need of critical care.”

READ  Businesses can use IGST credit to settle centre, state tax dues: CBIC

With such mobile ECG devices physicians can still keep track of their patients’ health even while they’re at home.

“I think that we’re going to see a much bigger focus on digitized healthcare in the next 10 years. It’s clearly been established as an important goal for the Indian government with the National Digital Health Mission, which will significantly improve efficiency and transparency in healthcare services. Because of this push and efforts by the Indian government, I think we can expect that remote heart monitoring will be the norm for everyone–whether for prevention or management of chronic disease. Technology like a mobile ECG device is already making this possible. I think India will see a surge in the demand and usage of digital health like never before,” David added.

AliveCor’s KardiaMobile 6L is priced at Rs 14000 and KardiaMobile is priced at Rs 8500.





READ SOURCE

LEAVE A REPLY

Please enter your comment!
Please enter your name here